Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Zhamak Khorgami
Saeed Shoar
Alan A. Saber
C. Anthony Howard
Goodarz Danaei
Guido M. Sclabas
机构：
[1] University of Oklahoma,Department of Surgery, College of Medicine
[2] Bariatric and Metabolic Institute,Department of Surgery, The Brooklyn Hospital Center, Icahn School of Medicine at Mount Sinai
[3] Newark Beth Israel Medical Center,Department of Surgery
[4] Harvard TH Chan School of Public Health,Department of Global Health and Population
[5] Harvard TH Chan School of Public Health,Department of Epidemiology
来源：
Obesity Surgery | 2019年 / 29卷
关键词：
Type 2 diabetes mellitus; Obesity; Medical management; Bariatric surgery; Treatment outcome; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：964 / 974
页数：10
相关论文
共 50 条
  • [41] Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
    WU HongXU MaojinZOU DajinHAN Qiaojun and HU Xue Department of EndocrinologyChanghai HospitalSecond Military Medical UniversityShanghai China
    中华医学杂志（英文版）, 2010, (20) : 2908 - 2913
  • [42] Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus A meta-analysis of randomized controlled trials
    Feng, Miao
    Lv, Haihong
    Xu, Xia
    Wang, Jue
    Lyu, Wenyi
    Fu, Songbo
    MEDICINE, 2019, 98 (30)
  • [43] BROMOCRIPTINE FOR THE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF RANDOMIZED CONTROLLED CLINICAL TRIALS
    Dasari, A.
    Gudala, K.
    Bansal, D.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S13 - S13
  • [44] Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials
    Zhu, Hongmei
    Zhu, Shuang
    Zhang, Xiuqian
    Guo, Yang
    Shi, Yunzhen
    Chen, Zhimin
    Leung, Siu-wai
    DIABETOLOGY & METABOLIC SYNDROME, 2013, 5
  • [45] Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
    Feiyu Wang
    Yinjun Mao
    Hang Wang
    Yiwei Liu
    Pinfang Huang
    Clinical Drug Investigation, 2022, 42 : 17 - 28
  • [46] Semaglutide and Diabetic Retinopathy Risk in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
    Wang, Feiyu
    Mao, Yinjun
    Wang, Hang
    Liu, Yiwei
    Huang, Pinfang
    CLINICAL DRUG INVESTIGATION, 2022, 42 (01) : 17 - 28
  • [47] PRISMA-efficacy and safety of lixisenatide for type 2 diabetes mellitus A meta-analysis of randomized controlled trials
    Wei, Zhen-gang
    Wang, Man-cai
    Zhang, Hui-han
    Wang, Zhe-yuan
    Wang, Gen-nian
    Wei, Feng-xian
    Zhang, Ya-wu
    Xu, Xiao-dong
    Zhang, You-cheng
    MEDICINE, 2018, 97 (51)
  • [48] Efficacy of flavonoids on biomarkers of type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
    Liu, Fanling
    Sirisena, Sameera
    Ng, Ken
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2023, 63 (21) : 4916 - 4941
  • [49] Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Hagi, Katsuhiko
    Nitta, Masahiro
    Watada, Hirotaka
    Kaku, Kohei
    Ueki, Kohjiro
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (11) : 1246 - 1261
  • [50] Psychosocial intervention for patients with type 2 diabetes mellitus and comorbid depression: a meta-analysis of randomized controlled trials
    Xie, Jing
    Deng, Wuquan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2681 - 2690
12345